Prostate cancer ... lesions than osteoblastic lesions [10]. The most useful investigation used nowadays for assessing whether the disease and its metastasis, especially bone metastasis, are active or ...

(UroToday.com) At the 2021 Society of Nuclear Medicine & Molecular Imaging (SNMMI) Meeting’s Correlative Cross-Sectional and Molecular Imaging session, Dr. Preeti Sukerkar discussed CT and MRI ...

Results: Among the 327 patients, 224 (68.50%) were diagnosed with benign, 65 (19.87%) with csPCa, and 38 (11.62%) with clinically insignificant prostate cancer (cisPCa). Prostate-specific antigen ...